NMD Pharma appoints Daniel Brennan as SVP, Corporate and Commercial Strategy

[ad_1] Daniel Brennan brings over 25 years of strategic commercial experience leading public and private rare disease and CNS biopharma companies Aarhus, Denmark, 1 June 2023 – NMD Pharma A/S,…